226 Views
Sunday Poster Session
Category: Biliary/Pancreas
Sherif Saleh, MD
MetroHealth Medical Center
Cleveland, OH, United States
| CCA Total(n=46) | CCA with psychiatric illness (n=17) | CCA with no psychiatric illness(n=29) | P-value |
Age (mean, sd) | 64.4, 11.1 | 65.3, 10.7 | 63.9, 11.5 | 0.55 |
Gender 0.93 | ||||
Male | 22 (47.8%) | 8 (47.1%) | 14 (48.3%) |
|
Female | 24 (52.2%) | 9 (52.9%) | 15 (51.7%) |
|
Race |
|
|
| 0.67 |
AA | 14 (30.4%) | 6 (35.3%) | 8 (27.6%) |
|
White | 25 (54.3%) | 9 (52.9%) | 16 (55.2%) |
|
Asian | 1 (2.2%) | 0 (0%) | 1 (3.4%) | |
Liver disease etiology |
|
|
| 0.33 |
HCV | 11 (23.9%) | 6 (35.3%) | 5 (17.2%) |
|
Alcohol | 7 (15.2%) | 3 (17.6%) | 4 (13.8%) |
|
NASH | 3 (6.5%) | 0 (0%) | 3 (10.3%) | |
Screening prior to CCA diagnosis 0.04 | ||||
< 6 month | 31 (67.4%) | 9 (52.9%) | 7 (24.1%) | |
>= 6 months | 15 (32.6%) | 8 (47.1%) | 22 (75.9%) | |
MELD at dx (mean, SD) | 10.9, 9.1 | 6.5, 6.3 | 15.2, 9.7 | 0.04 |
Metastatic at initial diagnosis 0.14 | ||||
Yes | 32 (69.6%) | 10 (58.8%) | 5 (17.2%) |
|
No | 12 (26.1%) | 7 (41.2%) | 22 (75.9%) |
|
Treatment decision at tumor board 0.25 | ||||
Resection, transplantation, radiotherapy | 15 (32.6%) | 5 (29.4%) | 10 (34.5%) | |
Chemotherapy or hospice | 29 (63.0%) | 11 (64.7%) | 18 (62.1%) |